(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual revenue growth rate of 5.05% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Whitehawk Therapeutics's revenue in 2025 is $27,775,000.On average, 1 Wall Street analysts forecast WHWK's revenue for 2025 to be $5,045,405,280, with the lowest WHWK revenue forecast at $5,045,405,280, and the highest WHWK revenue forecast at $5,045,405,280. On average, 1 Wall Street analysts forecast WHWK's revenue for 2028 to be $1,634,692,467, with the lowest WHWK revenue forecast at $1,634,692,467, and the highest WHWK revenue forecast at $1,634,692,467.
In 2029, WHWK is forecast to generate $1,761,887,558 in revenue, with the lowest revenue forecast at $1,761,887,558 and the highest revenue forecast at $1,761,887,558.